盐酸赛洛唑啉
xylometazoline hcl;2-(4-tert-butyl-2,6-dimethylbenzyl)-2-imidazolinmonohydrochloride;2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-1h-imidazol;otrivinehydrochloride;otrivinhydrochloride;XYLOMETAZOLINE HYDROCHLORIDE;XYLOMETAZOLIN HYDROCHLORIDE;2-(4-TERT-BUTYL-2,6-DIMETHYLBENZYL)-2-IMIDAZOLINE HYDROCHLORIDE;Xylometazoline (hydrochloride);Xylometazoline Hydro;2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole,hydrochloride;MLS000069695;SMR000058526;DSSTox_RID_80760;DSSTox_CID_25223;DSSTox_GSID_45223;Xylometazoline hydrochloride, 98%;2-(4-tert-butyl-2,6-dimethylbenzyl)-4,5-dihydro-1h-imidazole hydrochloride;2-[(4-tert-butyl-2,6-dimethyl-phenyl)methyl]-4,5-dihydro-1H-imidazole hydrochloride;2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5;2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline hydrochloride;Xylometazoline hydrochloride;2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline Hydrochloride;XYLOMETAZOLINE HYDROCHLORIDE [EP MONOGRAPH];XYLOMETAZOLINE HYDROCHLORIDE [USP-RS];XYLOMETAZOLINE HYDROCHLORIDE [MART.];Xylometazoline hydrochloride, analytical standard;1218-35-5;s2576;Metarivin Soln. 0.1%;DTXSID3045223;NSC 757378;NCGC00094506-04;J-004686;CCG-39900;NSC757378;X 6000;DTXCID1025223;SCHEMBL41837;Q27293585;Xylometazoline hydrochloride, United States Pharmacopeia (USP) Reference Standard;Xylometazoline hydrochloride, European Pharmacopoeia (EP) Reference Standard;Neo-Synephrine II (TN);HY-B0475;SinosilNasal Decongestant;BCP22148;Xylometazoline hydrochloride, British Pharmacopoeia (BP) Reference Standard;1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, monohydrochloride;CAS-1218-35-5;Neo-Synephrine II;KS-5144;AC-8301;AKOS015895456;X0063;XYLOMETAZOLINE HYDROCHLORIDE [MI];1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, hydrochloride (1:1);NCGC00094506-03;FT-0603554;CHEMBL1256400;A804796;SR-01000000230-2;Otrivin hydrochloride;YGWFCQYETHJKNX-UHFFFAOYSA-N;NCGC00094506-05;XYLOMETAZOLINE HYDROCHLORIDE (USP MONOGRAPH);Prestwick_574;X5S84033NZ;XYLOMETAZOLINE HYDROCHLORIDE [WHO-DD];HMS1568N07;SR-01000000230;XYLOMETAZOLINE HYDROCHLORIDE (USP-RS);Tox21_501269;LP01269;EINECS 214-936-4;Z2242061948;XYLOMETAZOLINE HYDROCHLORIDE [VANDF];XYLOMETAZOLINE HYDROCHLORIDE [USP MONOGRAPH];NCGC00261954-01;Xylometazoline Hydrochloride ,(S);SW196748-3;Opera_ID_1744;Xylometazoline HCl;SPECTRUM1500614;NSC-757378;HMS1921K09;Rhinactin;NCGC00016101-02;2-(4-(tert-butyl)-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole hydrochloride;REGID_for_CID_5282386;MLS001076518;NS00081176;NCGC00094506-02;EU-0101269;2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline monohydrochloride;Tox21_110305_1;Xylometazoline hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material;Tox21_110305;UNII-X5S84033NZ;2-IMIDAZOLINE, 2-(4-tert-BUTYL-2,6-DIMETHYLBENZYL)-, MONOHYDROCHLORID...